Canada Primary Cells Market Size & Outlook, 2024-2030
Related Markets
Canada primary cells market highlights
- The Canada primary cells market generated a revenue of USD 172.3 million in 2023 and is expected to reach USD 301.1 million by 2030.
- The Canada market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, human primary cells was the largest revenue generating origin in 2023.
- Human Primary Cells is the most lucrative origin segment registering the fastest growth during the forecast period.
Primary cells market data book summary
| Market revenue in 2023 | USD 172.3 million |
| Market revenue in 2030 | USD 301.1 million |
| Growth rate | 8.3% (CAGR from 2024 to 2030) |
| Largest segment | Human primary cells |
| Fastest growing segment | Human Primary Cells |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Animal Primary Cells, Human Primary Cells |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Lonza Group Ltd, PromoCell GmbH, ZenBio, STEMCELL Technologies, Axol Bioscience |
Other key industry trends
- In terms of revenue, Canada accounted for 8.5% of the global primary cells market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. primary cells market is projected to lead the regional market in terms of revenue in 2030.
- U.S. is the fastest growing regional market in North America and is projected to reach USD 996.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Primary Cells Market Scope
Primary Cells Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Axol Bioscience | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | https://www.axolbio.com |
| STEMCELL Technologies | View profile | 501-1000 | Vancouver, British Columbia, Canada, North America | https://www.stemcell.com |
| ZenBio | View profile | 11-50 | Durham, North Carolina, United States, North America | http://www.zen-bio.com/ |
| PromoCell GmbH | View profile | 51-100 | Heidelberg, Baden-Wurttemberg, Germany, Europe | http://www.promocell.com/ |
| Thermo Fisher Scientific Inc | View profile | 122000 | 168 Third Avenue, Waltham, MA, United States, 02451 | https://www.thermofisher.com |
| Lonza Group Ltd | View profile | 18000 | Muenchensteinerstrasse 38, Basel, Switzerland, CH-4002 | https://www.lonza.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
Canada primary cells market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to primary cells market will help companies and investors design strategic landscapes.
Human primary cells was the largest segment with a revenue share of 68.6% in 2023. Horizon Databook has segmented the Canada primary cells market based on animal primary cells, human primary cells covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Canada primary cells market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada primary cells market databook
-
Our clientele includes a mix of primary cells market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada primary cells market , including forecasts for subscribers. This country databook contains high-level insights into Canada primary cells market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada primary cells market size, by origin, 2018-2030 (US$M)
Canada Primary Cells Market Outlook Share, 2023 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
